A tumor marker for pancreatic cancer helps healthcare professionals detect, diagnose, or treat it. However, a person can have high tumor marker levels without having cancer. Tumor markers are ...
Tumor marker levels can be elevated in people with benign conditions. Tumor marker levels are not elevated in every person with cancer-especially in the early stages of the disease. Many tumor markers ...
Alongside high tumor marker levels, stage 3 testicular cancer has either spread to distant areas or nearby lymph nodes. The most common treatment options are surgery and chemotherapy. Stage 3 ...
Validating Risk Prediction Models for Multiple Primaries and Competing Cancer Outcomes in Families With Li-Fraumeni Syndrome Using Clinically Ascertained Data Using a training/validation study design, ...
Researchers in Japan have developed a predictive model that could improve treatment decisions for advanced pancreatic cancer patients. By combining tumor marker readings with patients' genetic ...
A 69 year old female patient with cancer in the head (widest part) of the pancreas spreading to a major abdominal artery (left image). After combined chemotherapy and radiation treatment, the tumor ...
Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...
Stage 0 testicular cancer is limited to the small tubes inside your testicles that produce sperm. It hasn’t spread to nearby or distant organs or caused an increase in tumor markers in your blood.
A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a ...
Immunotherapy has revolutionized the way physicians treat patients with cancer. Various immunotherapies have been developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results